Recent 11th Circuit Decision Is a Victory for Health Care Providers Challenging Insurer Reimbursement Decisions and a Reminder of the Importance of Carefully-Drafted Assignment of Benefits Clauses

by K&L Gates LLP

K&L Gates LLP

The existence and scope of assignments of benefits from patients to health care providers continues to be critically important to a provider’s ability to challenge an insurer’s reimbursement decision under the Employee Retirement Income Security Act of 1974 (“ERISA”). While providers lack independent standing under the statute, which may be a provider’s only ability to challenge an insurer’s reimbursement decision in court, they frequently rely on an assignment of benefits (“AOB”) as a basis for derivative standing.

As payor-provider reimbursement litigation has increased, courts have closely analyzed the language of AOBs to determine whether they are sufficiently broad to confer derivative standing on providers. If the court finds that the AOB language is sufficient to confer derivative standing, the provider may assert claims against an insurer under ERISA. By contrast, if the AOB language is insufficient to confer derivative standing on the provider, the provider does not have the ability to challenge an insurer’s reimbursement decision under ERISA or otherwise.

In a February 4, 2016 Alert, for example, we reported on the district court’s opinion in BioHealth Medical Laboratories, Inc. v. Connecticut General Life Insurance Company [1]. The facts and procedural history of the case follow a pattern similar to other cases brought by providers against commercial payors. In that case, out-of-network laboratories (the “Laboratories”) performed blood and urine testing pursuant to plans both issued and administered by defendants (“Cigna”) and sought reimbursement for those services from Cigna. Cigna either denied or delayed payment and the Laboratories filed suit challenging Cigna’s conduct under ERISA, relying on AOBs that they had received from their patients. Cigna then moved to dismiss the Laboratories’ claims, claiming, among other things, that the AOBs did not provide the Laboratories with standing to recover benefits arising from self-funded plans (i.e., those administered by Cigna).

The district court agreed with Cigna and the Laboratories appealed that decision to the Eleventh Circuit Court of Appeals. In an August 14, 2017 unpublished opinion, the Court of Appeals vacated the portion of the district court’s decision relating to the Laboratories’ standing to recover benefits arising from self-funded plans and allowed those claims to proceed. Specifically, the Court of Appeals, like other courts interpreting assignments, focused on the plain language of the AOBs at issue and, in particular, their reference to “collateral sources.” The Court of Appeals determined that the Laboratories’ interpretation of that phrase — which, under Florida law, included self-funded plans — was plausible at this juncture and, at the very least, necessitated discovery into extrinsic evidence before the AOB could be definitively interpreted. Thus, the district court’s dismissal of the Laboratories’ claims relating to self-funded plans was premature.

On a broader level, the Court of Appeals also explained that interpreting the AOBs to include self-funded plans would not thwart ERISA’s purposes of protecting the interests of employees and their beneficiaries in employee benefit plans and uniformity in plan administration. Instead, the Court underscored that such an interpretation may further those purposes by enabling providers — who may be “better situated and financed” than patients themselves — to challenge insurer reimbursement decisions.

The Court of Appeals’ decision further underscores the importance of carefully drafting AOBs and is a timely reminder for providers to review the assignment language included on their patient intake forms. The existence and scope of AOBs will continue to be heavily litigated issues in provider disputes with payors and providers would be well-served to give attention to the issue now, before they find themselves involved in a reimbursement dispute with an insurer.


1. See BioHealth Medical Laboratories, Inc. v. Connecticut General Life Insurance Company, No. 16-10978, 2017 BL 282904, (11th Cir. Aug. 14, 2017).


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© K&L Gates LLP | Attorney Advertising

Written by:

K&L Gates LLP

K&L Gates LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.